| Date |
Title |
Rating |
| 2009-08-31 |
MRRI research study to investigate how zolpidem might restore consciousness for patients in the vegetative state |
5 |
| 2009-08-31 |
Walgreens to provide flue shots faster and easier this season |
None |
| 2009-08-31 |
Nutra Pharma’s Cobroxin pain reliever is "Best New Product" at the ECRM Conference |
3.2 |
| 2009-08-31 |
Takeda visits managed care professionals to promote its two new drugs |
None |
| 2009-08-31 |
Cancer researcher to serve as Peregrine Pharmaceuticals' clinical advisor for bavituximab cancer program |
None |
| 2009-08-31 |
Tianyin Pharmaceutical to discuss its diversified product portfolio at the Rodman & Renshaw Annual Global Investment Conference |
None |
| 2009-08-31 |
New Drug Application for VIMOVO accepted by U.S. Food and Drug Administration |
5 |
| 2009-08-31 |
Doxorubicin granted orphan drug designation by the FDA |
None |
| 2009-08-31 |
IntelGenx Technologies shareholder conference call to update shareholders on CPI-300 |
None |
| 2009-08-31 |
Nuevolution partners with Novartis for drug research |
None |
| 2009-08-31 |
FDA approves the usage of Valcyte for preventing CMV disease in pediatric patients |
None |
| 2009-08-31 |
Oral dabigatran etexilate reduces the risk of stroke and systemic embolism |
5 |
| 2009-08-30 |
Intermediate dosages of otamixaban reduce acute coronary complications |
None |
| 2009-08-29 |
Research and Markets launches new report on the Worldwide Biological Product Manufacturing industry |
None |
| 2009-08-29 |
Court reverses the summary judgement decision on ANDA Patent litigation between Ortho McNeil and Caraco Pharmaceutical Laboratories |
None |
| 2009-08-29 |
Office of Orphan Products Development of the FDA grants Orphan Drug Designation to Quinazoline495 |
None |
| 2009-08-29 |
Genzyme’s supplemental NDA for treating adult AML with Clolar to be discussed by the FDA |
None |
| 2009-08-29 |
FDA approves Watson Pharmaceuticals' ANDA for Levonorgestrel tablets |
None |
| 2009-08-28 |
Milestone reached in Biotie Wyeth collaboration for the development of PDE10 inhibitors for schizophrenia |
None |
| 2009-08-28 |
New report on the world market for biogenerics is available from Reportlinker |
None |
| 2009-08-28 |
U.S. FDA agrees to the study design for cardiovascular outcomes trial of alogliptin |
None |
| 2009-08-28 |
Sagent Pharmaceuticals adds fluconazole injection to its line of premixed bags |
None |
| 2009-08-28 |
Kenya launches malaria campaign; PBS' newshour airs segment on drug-resistance in Cambodia |
None |
| 2009-08-28 |
Elorac offers Zithranol-RR for treating plaque psoriasis |
None |
| 2009-08-28 |
AVANIR raises funds to develop and commercialize Zenvia for PBA |
None |
| 2009-08-28 |
Fast Forward selects IntraLinks to support its funding effort |
None |
| 2009-08-28 |
Kamada finalizes agreement for the distribution of its intravenous alpha-1 antitrypsin in the United States |
5 |
| 2009-08-28 |
Leicester research reveals the detrimental effects of Beta blockers on central aortic pressures |
None |
| 2009-08-27 |
Report on Chinese markets for antibiotics available from Reportlinker |
None |
| 2009-08-27 |
Mylan Pharmaceuticals markets FDA approved first generic version of Sanofi Aventis' BenzaClin |
4 |
| 2009-08-27 |
China could become the fifth largest drug market by 2010-11 |
None |
| 2009-08-27 |
Geron provides additional comments on the recent clinical hold of Spinal Cord Injury IND |
3 |
| 2009-08-27 |
Market report evaluating the global market opportunity for transdermal pain management from Research And Markets |
None |
| 2009-08-27 |
Report on the top 10 pharmaceutical companies in India from Research And Markets |
3 |
| 2009-08-27 |
Clinical data added to ORENCIA labeling help treat patients with rheumatoid arthritis |
None |
| 2009-08-27 |
Viral Genetics cautions investors and the public to rely only on its own releases and disclosures |
None |
| 2009-08-27 |
European Medicines Agency validates Schering-Plough's MAA for nomegestrol acetate/17 beta-estradiol |
None |
| 2009-08-27 |
Prescription Solutions launches consumer website that features updated content and drug pricing tool |
5 |
| 2009-08-27 |
XenaCare Holdings to market Cobroxin pain reliever drug in U.S. |
None |
| 2009-08-27 |
European Medicines Agency accepts reviewal of Merck's MAA for regulatory approval of vernakalant IV |
None |
| 2009-08-27 |
Rizer XL's male enhancement formula increases sexual desire, pleasure and performance |
None |
| 2009-08-27 |
QRxPharma completes its pilot evaluation study investigating the efficacy of MoxDuo capsules |
5 |
| 2009-08-27 |
Walgreens collaborates with Caterpillar to provide transparent prescription drug pricing for employers |
None |
| 2009-08-27 |
FDA advisory panel recommends ban of pain medications Vicodin and Percocet |
1 |
| 2009-08-26 |
New over-the-counter eye drop provides relief to seven symptoms of eye irritation |
None |
| 2009-08-26 |
Endo Pharmaceuticals gets exclusive rights to commercialize ProStrakan's FORTESTA in the U.S. |
None |
| 2009-08-26 |
UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies |
None |
| 2009-08-26 |
Endo Pharmaceuticals Solutions announces the beginning of cash tender offer |
None |
| 2009-08-26 |
USP and FEUM agrees to collaborate on the development of standards for medicines |
None |
| 2009-08-26 |
DAS181 inhibits H5N1 Influenza lung virus infection of human lung tissues |
None |
| 2009-08-26 |
Modest decline for hypertension drug industry over the next decade |
None |
| 2009-08-26 |
FDA to review Acorda Therapeutics’ NDA for Fampridine-SR |
4.7 |
| 2009-08-26 |
FDA accepts Labopharm's response for its novel trazodone formulation |
5 |
| 2009-08-26 |
Sabril (vigabatrin) Oral Solution receives approval from FDA |
None |
| 2009-08-26 |
Glaxosmithkline affirms safety of Alli |
None |
| 2009-08-26 |
Study on effectiveness of CareFusion's ChloraPrep patient preoperative skin preparation published |
None |
| 2009-08-26 |
FDA issues warning letters to eight companies for selling illegal OTC ibuprofen drugs |
None |
| 2009-08-26 |
Gloucester Pharmaceuticals raises funds for the development of romidepsin |
None |
| 2009-08-26 |
Profectus BioSciences to conduct proof-of-concept studies with its rVSV vector technology |
None |
| 2009-08-26 |
Hiberix receives accelerated approval from FDA to overcome nationwide shortage |
None |
| 2009-08-25 |
ParagonRx's CEO recommends techniques to effectively manage the FDA-mandated REMS program |
None |
| 2009-08-25 |
Gastrointestinal (Stomach) Cancer Therapy Area Pipeline report available from Research and Markets |
None |
| 2009-08-25 |
Cytrx’s study offers a better perception of arimoclomol's mechanism of action in induced animal stroke |
None |
| 2009-08-25 |
PerkinElmer launched its second Good Manufacturing Practice facility for radiosynthesis of potential drug compounds |
None |
| 2009-08-25 |
Bavarian Nordic begins negotiations with U.S. to secure a contract to develop a freeze-dried version of smallpox vaccine |
None |
| 2009-08-25 |
FDA accepts for filing Salix Pharmaceuticals' NDA for rifaximin tablets |
None |
| 2009-08-25 |
Portola Pharmaceuticals' investigational antiplatelet drug elinogrel featured at the ESC Congress 2009 |
5 |
| 2009-08-25 |
Blue Spoon outlines a new strategy for pharmaceutical industries |
None |
| 2009-08-25 |
Nutra Pharma submits final packaging and labeling for Cobroxin drug for FDA approval |
None |
| 2009-08-25 |
Lpath achieves one of the four Phase 1 objectives by demonstrating its optimized fermentation process |
None |
| 2009-08-25 |
Pharmacy Times serves as a go-to resource for pharmacists on OTC products |
None |
| 2009-08-25 |
FDA issues final approval for manufacturing and marketing Ranbaxy's Glycopyrrolate tablets |
None |
| 2009-08-25 |
Thyretain TSI Reporter BioAssay test for detecting auto-antibodies attains the FDA clearance |
None |
| 2009-08-25 |
Myoderm expands its portfolio to include drug procurement, management and distribution services |
None |
| 2009-08-25 |
UCB and sanofi-aventis U.S. receive FDA's approval for XYZAL to treat allergies in children |
4.5 |
| 2009-08-25 |
FDA issues marketing approval for APP Pharmaceuticals' Penicillin G potassium for Injection, USP |
None |
| 2009-08-25 |
NIAID funds Nanotherapeutic for developing an inhaled version of the injectable antiviral drug |
None |
| 2009-08-25 |
FDA issues warning letter to Cambrex concerning its Italian API manufacturing facility |
None |
| 2009-08-24 |
Bioniche Life Sciences update on Phase III clinical program for evaluating Urocidin |
None |
| 2009-08-24 |
WHO appeals for donated, low-cost H1N1 vaccines |
None |
| 2009-08-24 |
Orphan drug status granted to BioCancell's BC-819 drug |
None |
| 2009-08-24 |
P&G's global pharmaceuticals business sold to Warner Chilcott for $3.1 billion |
None |
| 2009-08-24 |
Santaris Pharma to discover and develop new RNA-based medicines for treating rare genetic disorders |
None |
| 2009-08-24 |
Osteologix announces receipt of Decision to Grant a Patent from JPO for NB S101 osteoporosis drug candidate |
None |
| 2009-08-24 |
Simcere to collaborate with Sun Yat-Sen University Cancer Center to research and develop anti-cancer drugs |
None |
| 2009-08-24 |
Phase 2 clinical study of Resolvin RX-10045 for dry eye syndrome provides positive data |
None |
| 2009-08-24 |
PLoS Medicine's editors to eventually stamp ghostwriting |
None |
| 2009-08-24 |
NovaBay Pharmaceuticals to deliver two poster presentations describing results from new studies of NVC-422 |
None |
| 2009-08-24 |
Cell Therapeutics' NDA for Pixantrone accepted by the FDA |
None |
| 2009-08-24 |
Biovail enters into an agreement with Santhera to develop and market JP-1730/fipamezole drug |
None |
| 2009-08-24 |
Simcere Pharmaceutical Group's forty-two generic drugs included in China's Essential Drug List |
None |
| 2009-08-24 |
Pharmaceutical manufacturers increase lobbying |
None |
| 2009-08-24 |
Discovery of genetic biomarkers enable targeted personalised medication for Colorectal cancer |
5 |
| 2009-08-24 |
Lundbeck to launch Sabril in the US following FDA's NDA approval |
None |
| 2009-08-24 |
Biovail's patent infringement lawsuit against Cary Pharma may affect IntelGenx revenues |
None |
| 2009-08-23 |
FDA issues complete response letter regarding the NDA for carisbamate |
None |
| 2009-08-22 |
Adamas Pharmaceuticals forges agreement with U.S. Naval Health Research Center for evaluating triple combination antiviral drug |
None |
| 2009-08-21 |
Cortex Pharmaceuticals receives delisting notification from NYSE Amex |
None |
| 2009-08-21 |
FDA approves Epocal's new glucose test on the epoc Blood Analysis System |
None |
| 2009-08-21 |
Nutra Pharma launches Cobroxin for chronic pain relief |
None |
| 2009-08-21 |
Takeda Canada reacquires commercial rights for an oral type 2 diabetic treatment drug |
2 |
| 2009-08-21 |
Syntagon to deliver presentation on controlling genotoxic impurities |
None |
| 2009-08-21 |
Medicago and Ajanta Pharma forge MoU to commercialize seasonal influenza VLP-based vaccines in India |
None |
| 2009-08-21 |
New antimalarial drug discovery project funded by European Commission |
None |
| 2009-08-21 |
Newspapers examine debate over affordable drugs in developing countries |
None |
| 2009-08-21 |
U.S District Court grants preliminary approval for the settlement of Sampson v. Robinson case |
None |
| 2009-08-21 |
Health Canada approves Anika Therapeutics' MONOVISC drug |
None |
| 2009-08-21 |
Influenza A H1N1 Real Time RT-PCR tests detect RNA of H1N1 influenza virus |
None |
| 2009-08-21 |
AMDL Diagnostics to focus on in vitro diagnostic cancer tests |
None |
| 2009-08-20 |
Federal guidelines for seasonal and swine flu vaccines questioned |
None |
| 2009-08-20 |
Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: Population-based cohort study |
2 |
| 2009-08-20 |
Consumer groups urge transparency in health care reform for pharmacy benefit managers |
None |
| 2009-08-20 |
Cambodia's maternal mortality; drugs in Uganda; cholera risk in Zimbabwe; HIV laws in Niger |
None |
| 2009-08-20 |
Chemical components of elderberry, cinnamon and green tea extracts block HIV viruses from infecting cells |
4 |
| 2009-08-20 |
Advaxis awarded $210,000 for development of a dual antigen vaccine |
None |
| 2009-08-20 |
Seasonal flu vaccinations to cost less in Safeway's U.S. Stores |
None |
| 2009-08-20 |
RBC Life Sciences reports on patent-pending, nutritional supplement |
5 |
| 2009-08-20 |
Wraser purchases Trezix oral capsule product from e5 Pharma |
5 |
| 2009-08-20 |
Aton Pharma markets preservative-free drugs for glaucoma |
None |
| 2009-08-20 |
Imagenetix announces retail distribution of InflameAway Celadrin(R) gels for promoting joint health |
None |
| 2009-08-19 |
Phrma brushes off Republican leader's attacks |
None |
| 2009-08-19 |
FDA approves Hiberix Haemophilus influenzae type b vaccine |
None |
| 2009-08-19 |
Mylan files lawsuit against Pittsburgh Post-Gazette, Post-Gazette reporters |
5 |
| 2009-08-19 |
The Gambia introduces pneumococcal immunisation programme |
None |
| 2009-08-19 |
AstraZeneca Canada files a New Drug Submission (NDS) for FluMist in Canada |
None |
| 2009-08-19 |
H1N1 vaccine orders top 1 billion, WHO Says |
None |
| 2009-08-19 |
U.S. FDA approval of miconazole MBT represents a significant milestone for Strativa Pharmaceuticals |
4 |
| 2009-08-19 |
Omnia Biologics and Aparna Biosciences sign agreement on lentivirus drug development |
None |
| 2009-08-19 |
CEL-SCI expands work on current H1N1 virus vaccine |
None |
| 2009-08-19 |
Light-activated delivery system enhances anti-tumour drug potency |
None |
| 2009-08-19 |
Orient Pharma granted commercialization rights for a drug candidate by DURECT |
None |
| 2009-08-19 |
BioAlliance Pharma's new drug application for oropharyngeal candidiasis treatment accepted by the FDA |
None |
| 2009-08-19 |
CSL Biotherapies to supply Afluria influenza vaccines from newly licensed packaging facility |
None |
| 2009-08-19 |
New production technology to develop vaccine for norovirus |
5 |
| 2009-08-19 |
SFDA approves China Pharma Holdings' generic Omeprazole Sodium injection |
None |
| 2009-08-19 |
FDA places Geron Corporation's IND for spinal cord injury on clinical hold |
4.9 |
| 2009-08-19 |
Amira Pharmaceuticals submits IND for inflammatory and allergic disease treatment candidate |
None |
| 2009-08-18 |
Gloucester Pharma announces FDA Advisory Committee Meeting to discuss Romidepsin NDA |
None |
| 2009-08-18 |
Labopharm comments on outcome of patent-infringement litigation initiated by Purdue Pharma |
None |
| 2009-08-18 |
Par Pharmaceutical wins in Ultram ER litigation |
None |
| 2009-08-18 |
Synco Bio to manufacture Versartis type 2 diabetes drug candidate |
None |
| 2009-08-17 |
Boehner blasts Phrma on deal with White House |
None |
| 2009-08-17 |
FDA approves Helixate FS for routine prophylaxis in children with hemophilia A |
None |
| 2009-08-17 |
Alpharx completes lyophilization process for Zysolin |
None |
| 2009-08-17 |
GSK starts testing H1N1 vaccine; Opinion piece addresses U.S. role in helping developing countries procure vaccine |
None |
| 2009-08-17 |
FDA approves Extavia for multiple sclerosis |
None |
| 2009-08-17 |
Astronauts test nutritional supplement formulas in space |
5 |
| 2009-08-14 |
Mylan Pharmaceuticals receives final FDA report on Morgantown, W.Va., manufacturing facility |
None |
| 2009-08-13 |
CVS Caremark announces results of 2009 Health IQ study |
None |
| 2009-08-13 |
Sigma-Aldrich offers customizable synthetic extracellular matrix (ECM) for stem cell research |
None |
| 2009-08-13 |
Stanford researchers want FDA to require drug makers to state how new medications compare with similar, existing treatments |
None |
| 2009-08-12 |
Dynavax announces European development strategy for investigational adult hepatitis B vaccine in Europe |
None |
| 2009-08-12 |
Bristol-Myers Squibb announces Hart-Scott-Rodino Review period for Medarex acquisition expired |
None |
| 2009-08-12 |
Nanoviricides herpes study discussed on CBS News report |
4 |
| 2009-08-12 |
Health Canada approves Multaq (Dronedarone) for atrial fibrillation |
3 |
| 2009-08-12 |
Forest Labs and Astrazeneca to co-develop and commercialize ceftaroline |
None |
| 2009-08-12 |
Providers, patients in States face budget squeeze |
None |
| 2009-08-12 |
Schering-Plough announces agreement with Orchid Chemicals & Pharmaceuticals on generic forms of CLARINEX |
None |
| 2009-08-12 |
Ranbaxy receives approval to market Sumatriptan Succinate tablets |
None |
| 2009-08-12 |
Scientists discover how new drug kills roundworms |
None |
| 2009-08-11 |
Labopharm submits response to FDA for formulation of the antidepressant trazodone |
None |
| 2009-08-11 |
Teva announces approval of Oxaliplatin injection |
None |
| 2009-08-11 |
Hospira launches generic version of Sanofi-Aventis' Eloxatin |
None |
| 2009-08-11 |
Britain's first swine flu vaccine trials start |
None |
| 2009-08-11 |
New type of anti-clotting drug called Apixaban |
None |
| 2009-08-11 |
PTC Therapeutics achieves milestone in Schering-Plough hepatitis C collaboration |
None |
| 2009-08-11 |
Upstream Biosciences actively seeking licensors or acquirers for anti-parasitic drug discovery portfolio and cancer diagnostic platform |
5 |
| 2009-08-11 |
Seattle Genetics reaches milestone under collaboration agreement with MedImmune |
None |
| 2009-08-11 |
Easy-to-swallow drug restores autoimmune function in diabetics |
None |
| 2009-08-11 |
Genzyme updates on Cerezyme supply plus 2009 financials |
None |
| 2009-08-10 |
Mylan receives FDA approval for generic Imitrex |
None |
| 2009-08-10 |
Cephalon, Inc. completes acquisition of Arana Therapeutics |
None |
| 2009-08-10 |
CDC expands existing vaccine distribution partnership with Mckesson to include H1N1 flu vaccine |
None |
| 2009-08-10 |
Vion Pharmaceuticals announces ODAC meeting for lead oncology therapeutic Onrigin |
None |
| 2009-08-10 |
Automated dispensing unit provides more accurate pharmacy automation |
None |
| 2009-08-10 |
Nanoviricides anti-herpes drug candidate reduces viral load by 99.99% |
2 |
| 2009-08-10 |
ISI to host eSolutions Conference in September 2009 |
None |
| 2009-08-10 |
Sharing prescription advice among adolescents can have dangerous repercussions |
None |
| 2009-08-10 |
FDA approves APP Pharmaceuticals' Idarubicin HCI injection |
None |
| 2009-08-09 |
Expert available on recent FDA analysis of TNF blockers |
None |
| 2009-08-09 |
Watson recalls one lot of Fentanyl transdermal system |
None |
| 2009-08-09 |
Hard To Treat Diseases (HTDS) Chile flu vaccine tender |
5 |
| 2009-08-07 |
Sanofi Pasteur submits supplemental application for influenza A(H1N1) 2009 monovalent vaccine to FDA |
None |
| 2009-08-07 |
White House deal with drug industry sparks Democratic revolt |
None |
| 2009-08-07 |
Clinton Foundation reaches deal with Matrix, Pfizer to cut prices for second-line Arvs, TB drug |
None |
| 2009-08-07 |
Merck shareholders overwhelmingly approve merger with Schering-Plough |
None |
| 2009-08-07 |
H1N1 vaccine will be approved, ready for use by September, WHO says |
None |
| 2009-08-07 |
American Oriental Bioengineering launches new product for rhinitis and allergies |
None |
| 2009-08-06 |
Soliris (Eculizumab) granted orphan drug designation in Europe and U.S. for atypical hemolytic uremic syndrome |
None |
| 2009-08-06 |
Obama to drug industry: We still have a deal |
None |
| 2009-08-06 |
Celera and Aurora to collaborate on cardiovascular genetics |
None |
| 2009-08-06 |
Bill Clinton, Pfizer, and Mylan announce new agreements to lower prices of antiretrovirals for HIV/AIDS in the developing world |
None |
| 2009-08-06 |
Fast-tracked H1N1 vaccines will not compromise safety, WHO says |
None |
| 2009-08-06 |
Spectrum Pharmaceuticals acquires rights and IP for Renazorb |
None |
| 2009-08-06 |
Research details role of galectin-3 in heart failure |
None |
| 2009-08-06 |
Alnylam and Tekmira to collaborate on RNAi therapeutics |
None |
| 2009-08-06 |
Phytomedical partners with LATITUDE Pharmaceuticals on lead anti cancer compound for glioblastoma |
None |
| 2009-08-06 |
Innexus Biotechnology announces business development initiative on lead preclinical candidate |
None |
| 2009-08-06 |
Orexo: Abstral NDA submitted to U.S. FDA |
None |
| 2009-08-06 |
Genzyme’s Mozobil approved in Europe |
None |
| 2009-08-06 |
Biochemics and Pacific Pharmaceutical to collaborate on skin products |
None |
| 2009-08-05 |
Appeals court affirms invalidation of Yasmin patent |
None |
| 2009-08-05 |
Innovative diabetes drug discovery partnership |
None |
| 2009-08-05 |
Baxter completes production of batches of CELVAPAN A/H1N1 pandemic vaccine |
2 |
| 2009-08-05 |
Impax Labs receives FDA approval for generic version of Depakote |
None |
| 2009-08-05 |
Epicept files NDA for Ceplene in Canada |
None |
| 2009-08-04 |
New understanding on Gleevec's limitations |
5 |
| 2009-08-04 |
Evidence of Malaria origins, could lead to vaccine development |
None |
| 2009-08-04 |
Tuberculosis drugs under development could have large impact on the disease |
None |
| 2009-08-03 |
FDA approves Livalo (pitavastatin), a new cholesterol-lowering drug |
3.9 |
| 2009-08-03 |
Dysport, an anti-wrinkle alternative to Botox |
None |
| 2009-08-03 |
Comp. effectiveness promises better, cheaper health care but cricits link it to rationing |
None |
| 2009-08-03 |
House panel passes protection for drug makers |
None |
| 2009-08-03 |
FDA approves Avastin plus interferon-alfa for people with metastatic renal cell carcinoma |
None |
| 2009-08-03 |
US FDA approves Lipsovir for cold sores |
None |
| 2009-08-02 |
FDA approves Invega Sustenna for schizophrenia |
5 |
| 2009-08-02 |
FDA approves Onglyza (saxagliptin) for type 2 diabetes |
None |